SCHEMBL4755381

SCHEMBL4755381

CCOCc1nc2cnc3ccccc3c2n1N=CC(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 6/20 0.39
TLR8 Q9NR97 5/20 0.39
NUDT1 P36639 1/20 0.37
ALDH1A1 P00352 5/20 0.34
MYC P01106 1/20 0.34
MPO P05164 1/20 0.33
PDE10A Q9Y233 1/20 0.33
MAPT P10636 5/20 0.33
RAB9A P51151 2/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
TSHR P16473 3/20 0.33
NCF1 P14598 1/20 0.33
PLA2G1B P04054 1/20 0.33
ATG4B Q9Y4P1 1/20 0.33
LMNA P02545 4/20 0.32
HTT P42858 2/20 0.32
RECQL P46063 1/20 0.32
HPGD P15428 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4756669 0.87 TLR7 (0.37) TLR7TLR8NUDT1ALDH1A1MPO
SCHEMBL4756665 0.87 TLR7 (0.37) TLR7TLR8NUDT1ALDH1A1MPO
SCHEMBL5447365 0.85 ALDH1A1 (0.46) TLR7TLR8NUDT1ALDH1A1MAPT
SCHEMBL5810795 0.85 TLR8 (0.39) TLR7TLR8NUDT1ALDH1A1PDE10A
SCHEMBL5810799 0.85 TLR8 (0.39) TLR7TLR8NUDT1ALDH1A1PDE10A
SCHEMBL4790061 0.85 ALDH1A1 (0.46) TLR7TLR8NUDT1ALDH1A1MAPT
SCHEMBL4758685 0.81 ALDH1A1 (0.56) TLR7TLR8ALDH1A1MAPTRAB9A
SCHEMBL4758684 0.81 ALDH1A1 (0.56) TLR7TLR8ALDH1A1MAPTRAB9A
SCHEMBL4758103 0.80 TLR7 (0.41) TLR7TLR8NUDT1ALDH1A1MYC
SCHEMBL16802296 0.78 PDE10A (0.49) TLR7TLR8NUDT1PDE10ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1605943-A4 1-AMINO 1H-IMIDAZOQUINOLINES 3M INNOVATIVE PROPERTIES CO (US) 2008-01-16 EP disclosed
US-7163947-B2 1-Amino 1H-imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-01-16 US disclosed
WO-2006028451-A1 1-AMINO 1-H-IMIDAZOQUINOLINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-03-16 WO disclosed
EP-1605943-A2 1-AMINO 1H-IMIDAZOQUINOLINES 3M Innovative Properties Company (US) 2005-12-21 EP disclosed
US-20050054640-A1 1-Amino 1H-imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY 2005-03-10 US disclosed
WO-2004080398-A2 1-AMINO 1H-IMIDAZOQUINOLINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2004-09-23 WO disclosed
US-20040176367-A1 1-Amino 1H-imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176367-A1 1-Amino 1H-imidazoquinolines IL2, IFNG, IL4I1 TLR7 146/4885TLR8 507/4885NUDT1 728/4885
US-20050054640-A1 1-Amino 1H-imidazoquinolines IL2, IFNG, IL4I1 TLR7 146/4885TLR8 507/4885NUDT1 728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.